Michel Bourin

Pharmacy — University of Nantes, France

LeadR Profile

Michel Bourin University of Nantes France
1 066 ScienceLeadR Reputation 1066
Network Map

Pharmacy

Subspecialties: Psychiatry - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

- Medical Doctor, University of TOURS, 1979


- Pharmaceutical Doctor, University of TOURS, 1970


-Degrees in Neuropsychopharmacology, Clinical pharmacology and General Pharmacology, University of PARIS (1977-1978)


- Psychiatrist 1997 (National Committee of the French Medical Board)


-Psychiatrist presently in a centre for mental handicapped adults in Montredon (near Narbonne)


-Visiting Professor University of Craiova (Romania)

-WHO expert for drug dependence (2000-2016)


Organizations

Career arc: 1988 - 2026

Source: PubMed

University of Nantes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 387

Citations

Citations: 14 599 1st author: 111 Last author: 98 Unique author: 64


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Pharmacological evaluation frameworks in autism spectrum disorder: Methodological and neurobiological considerations.
autism spectrum disorder, genetics, biomarkers, autistic disorder, therapeutics, neurodevelopment
Pak J Pharm Sci20260
Understanding Psychotic Depression.
depression, antidepressive agents, hallucinations, prescriptions, signs and symptoms, antipsychotic agents, therapeutics, psychotic disorders, delusions
Adv Exp Med Biol20260
The Diagnosis of Bipolar Disorders: A Major Public Health Issue.
bipolar disorder, public health, diagnosis
Alpha Psychiatry20240
Bipolar Disorders and Seasonality
bipolar disorder
Journal of Mental Health Disorders20240
Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders.
cytokines, pharmaceutical preparations, mental disorders, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Adv Exp Med Biol20236

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 4 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map